Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 6/20 | 0.60 |
| ▸ | LMNA | P02545 | 5/20 | 0.60 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | LCK | P06239 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.52 |
| ▸ | CDK2 | P24941 | 1/20 | 0.51 |
| ▸ | BRD4 | O60885 | 3/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL31379723 | 0.98 | HTT (0.59) | HTTLMNAPDPK1CYP1A2PAK1 | |
| SCHEMBL21914 | 0.79 | HTT (0.62) | HTTLMNACYP1A2PAK1HIF1A | |
| SCHEMBL29380490 | 0.79 | HTT (0.62) | HTTLMNACYP1A2PAK1HIF1A | |
| SCHEMBL10918760 | 0.78 | HTT (0.60) | HTTLMNAPDPK1CYP1A2PAK1 | |
| SCHEMBL6243538 | 0.78 | HTT (0.60) | HTTLMNAPDPK1CYP1A2PAK1 | |
| SCHEMBL11591794 | 0.77 | HTT (0.59) | HTTLMNACYP1A2PAK1HIF1A | |
| SCHEMBL405823 | 0.76 | HTT (0.58) | HTTLMNACYP1A2PAK1HIF1A | |
| SCHEMBL6509992 | 0.76 | XDH (0.45) | HTTLMNAMAPT | |
| SCHEMBL29501839 | 0.76 | LMNA (0.57) | HTTLMNACYP1A2PAK1HSD17B10 | |
| SCHEMBL17901710 | 0.76 | HTT (0.57) | HTTLMNACYP1A2PAK1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025013869-A1 | FLUORINE-CONTAINING POLYMER HAVING NITROGEN-CONTAINING AROMATIC RING, PRODUCTION METHOD THEREFOR, AND COMPOSITION THEREOF | ダイキン工業株式会社 | 2025-01-16 | — | — | WO | claimed |
| US-20060223148-A1 | Process for sequence saturation mutagenesis (sesam) | BASF AKTIENGESCHAFT (DE) | 2006-10-05 | — | — | US | claimed |
| WO-1998001459-A1 | NOVEL N-ALKOXYADENINE DERIVATIVES ACTING AS CYTOKINE INHIBITORS | NOVO NORDISK A/S (DK) | 1998-01-15 | — | — | WO | claimed |
| US-12492428-B2 | Methods and compositions for the quantitation of mitochondrial nucleic acid | AGENA BIOSCIENCE, INC. (US) | 2025-12-09 | — | — | US | disclosed |
| US-12473595-B2 | Coupling method | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2025-11-18 | — | — | US | disclosed |
| US-20250290132-A1 | COUPLING METHOD | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2025-09-18 | — | — | US | disclosed |
| EP-4574993-A2 | METHODS AND PROCESSES FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS | Sequenom, Inc. (US) | 2025-06-25 | — | — | EP | disclosed |
| US-20250157582-A1 | METHODS AND PROCESSES FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS | SEQUENOM, INC. | 2025-05-15 | — | — | US | disclosed |
| EP-3540076-B1 | METHODS AND PROCESSES FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS | SEQUENOM INC (US) | 2025-05-07 | — | — | EP | disclosed |
| WO-2025013869-A1 | FLUORINE-CONTAINING POLYMER HAVING NITROGEN-CONTAINING AROMATIC RING, PRODUCTION METHOD THEREFOR, AND COMPOSITION THEREOF | ダイキン工業株式会社 | 2025-01-16 | — | — | WO | disclosed |
| CN-118119404-A | Immunogenic LNP compositions and methods thereof | 辉瑞公司 | 2024-05-31 | — | — | CN | disclosed |
| EP-1307592-A2 | SINGLE-LABELED OLIGONUCLEOTIDE PROBES | University of Utah Research Foundation (US) | 2003-05-07 | — | — | EP | disclosed |
| US-20030022177-A1 | Single-labeled oligonucleotide probes for homogeneous nucleic acid sequence analysis | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-01-30 | — | — | US | disclosed |
| WO-2002085309-A2 | COMPOSITION, FORMULATIONS & KITS FOR TREATMENT OF RESPIRATORY & LUNG DISEASE WITH ANTI-SENSE OLIGONUCLEOTIDES & A BRONCHODILATING AGENT | EPIGENESIS PHARMACEUTICALS, INC. (US) | 2002-10-31 | — | — | WO | disclosed |
| WO-2002014555-A2 | SINGLE-LABELED OLIGONUCLEOTIDE PROBES | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2002-02-21 | — | — | WO | disclosed |
| EP-1168919-A2 | LOW ADENOSINE ANTI-SENSE OLIGONUCLEOTIDE, COMPOSITIONS, KIT AND METHOD FOR TREATMENT OF AIRWAY DISORDERS ASSOCIATED WITH BRONCHOCONSTRICTION, LUNG INFLAMMATION, ALLERGY(IES) AND SURFACTANT DEPLETION | East Carolina University (US) | 2002-01-09 | — | — | EP | disclosed |
| WO-2000062736-A2 | LOW ADENOSINE ANTI-SENSE OLIGONUCLEOTIDE, COMPOSITIONS, KIT AND METHOD FOR TREATMENT OF AIRWAY DISORDERS ASSOCIATED WITH BRONCHOCONSTRICTION, LUNG INFLAMMATION, ALLERGY(IES) AND SURFACTANT DEPLETION | EAST CAROLINA UNIVERSITY (US) | 2000-10-26 | — | — | WO | disclosed |
| EP-0973788-A1 | TRICYCLIC BASE ANALOGUES | Amersham Pharmacia Biotech UK Limited (GB) | 2000-01-26 | — | — | EP | disclosed |
| WO-1998043991-A1 | TRICYCLIC BASE ANALOGUES | AMERSHAM PHARMACIA BIOTECH UK LIMITED (GB) | 1998-10-08 | — | — | WO | disclosed |
| WO-1998001459-A1 | NOVEL N-ALKOXYADENINE DERIVATIVES ACTING AS CYTOKINE INHIBITORS | NOVO NORDISK A/S (DK) | 1998-01-15 | — | — | WO | disclosed |